Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: Inhibitory effect of antioxidants

Journal of Leukocyte Biology

Volumn 75, Issue 6, 2004, Pages 1062-1069

  Mamputu, J C ^a   Renier, G ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

Adhesion molecules; AGE; Gliclazide; VEGF

Indexed keywords

1,2 PHENYLENEDIAMINE; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DIANISIDINE; GLIBENCLAMIDE; GLICLAZIDE; HEPARIN; I KAPPA B; INTERCELLULAR ADHESION MOLECULE 1; PROTEIN KINASE C INHIBITOR; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; GLYCATION; HUMAN; HUMAN CELL; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; RETINA; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CATTLE; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; GLICLAZIDE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MONOCYTES; NF-KAPPA B; PROTEIN KINASE C; RETINAL VESSELS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITAMIN E;

BOVINAE;

EID: 2642556463     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0603265     Document Type: Article

References (43)

1. Miyamoto, K., Ogura, Y. (1999) Pathogenetic potential of leukocytes in diabetic retinopathy. Semin. Ophthalmol. 14, 233-239.
2. Joussen, A. M., Murata, T., Tsujikawa, A., Kirchhof, B., Bursell, S-E., Adamis, A. P. (2001) Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol. 158, 147-152.
3. Miyamoto, K., Khosrof, S., Bursell, S. E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., Adamis, A. P. (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. USA 96, 10836-10841.
4. Joussen, A. M., Poulaki, V., Qin, W., Kirchhof, B., Mitsiades, N., Wiegand, S. J., Rudge, J., Yancopoulos, G. D., Adamis, A. P. (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol. 160, 501-509.
5. Barouch, F. C., Miyamoto, K., Allport, J. R., Fujita, K., Bursell, S. E., Aiello, L. P., Luscinskas, F. W., Adamis, A. P. (2000) Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest. Ophthalmol. Vis. Sci. 41, 1153-1158.
6. Miyamoto, K., Ogura, Y., Kenmochi, S., Honda, Y. (1997) Role of leukocytes in diabetic microcirculatory disturbances. Microvasc. Res. 54, 43-48.
7. Miyamoto, K., Khosrof, S., Bursell, S. E., Moromizato, Y., Aiello, L. P., Ogura, Y., Adamis, A. P. (2000) Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am. J. Pathol. 156, 1733-1739.
8. Stitt, A. W., Bhaduri, T., McMullen, C. B., Gardiner, T. A., Archer, D. B. (2000) Advanced glycation end products induce blood-retinal barrier dysfunction in normoglycemic rats. Mol. Cell. Biol. Res. Commun. 3, 380-388.
9. Leto, G., Pricci, F., Amadio, L., lacobinic, C., Cordone, S., Diaz-Horta, O., Romeo, G., Barsotti, P., Rotella, C. M., di Mario, U., Pugliese, G. (2001) Increased retinal endothelial cell monolayer permeability induced by the diabetic milieu: role of advanced non-enzymatic glycation and polyol pathway activation. Diabetes Metab. Res. Rev. 17, 448-458.
10. Segawa, Y., Shirao, Y., Yamagishi, S., Higashide, T., Kobayashi, M., Katsuno, K., Iyobe, A., Harada, H., Sato, F., Miyata, H., Asai, H., Nishimura, A., Takahira, M., Souno, T., Segawa, Y., Maeda, K., Shima, K., Mizuno, A., Yamamoto, H., Kawasaki, K. (1998) Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Ophthalmic. Res. 30, 333-339.
11. Murata, T., Nagai, R., Ishibashi, T., Inomuta, H., Ikeda, K., Horiuchi, S. (1997) The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas. Diabetologia 40, 764-769.
12. Mamputu, J. C., Renier, G. (2002) Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide. J. Diabetes Complications 16, 284-293.
13. Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., Adamis, A. P. (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest. 101, 1219-1224.
14. Hirata, C., Nakano, K., Nakamura, N., Kitagawa, Y., Shigeta, H., Hasegawa, G., Ogata, M., Ikeda, T., Sawa, H., Nakamura, K., lenaga, K., Obayashi, H., Kondo, M. (1997) Advanced glyeation end products induce expression of vascular endothelial growth factor by retinal Muller cells. Biochem. Biophys. Res. Commun. 236, 712-715.
15. Hoffmann, S., Friedrichs, U., Eichler, W., Rosenthal, A., Wiedemann, P. (2002) Advanced glycation end products induce choroidal endothelial cell proliferation, matrix metalloproteinase-2 and VEGF upregulation in vitro. Graefes Arch. Clin. Exp. Ophthalmol. 240, 996-1002.
16. Ido, Y., Chang, K. C., Lejeune, W. S., Bjercke, R. J., Reiser, K. M., Williamson, J. R., Tilton, R. G. (2001) Vascular dysfunction induced by AGE is mediated by VEGF via mechanisms involving reactive oxygen species, guanylate cyclase, and protein kinase C. Microcirculation 8, 251-263.
17. Basta, G., Lazzerini, G., Massaro, R., Simoncini, T., Tanganelli, P., Fu, C., Kislinger, T., Stem, D. M., Schmidt, A. M., De Caterina, R. (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105, 816-822.
18. Desfaits, A. C., Serri, O., Renier, G. (1999) Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin. Diabetes Obes. Metab. 1, 113-120.
19. Desfaits, A. C., Serri, O., Renier, G. (1997) Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism 46, 1150-1156.
20. Noda, Y., Mori, A., Paker, L. (1997) Gliclazide scavenges hydroxyl, superoxide, and nitric oxide radicals: an ESR study. Res. Commun. Mol. Pathol. Pharmacol. 96, 115-124.
21. O'Brien, R. C., Luo, M., Balazs, N., Mercuri, J. (2000) In vitro and in vivo antioxidant properties of gliclazide. J. Diabetes Complications 14, 201-206.
22. Nomura, H., Naito, M., Kodama, M., Kato, Y., Iguchi, A. (2000) Effects of gliclazide on low-density lipoprotein oxidizability and atherosclerosis in cholesterol-fed rabbits. J. Atheroscler. Thromb. 7, 104-109.
23. Aiello, L. P., Northrup, J. M., Keyt, B. A., Takagi, H., Iwamoto, M. A. (1995) Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch. Ophthalmol. 113, 1538-1544.
24. Mentzer, S. J., Guyre, P. M., Burakoff, S. J., Faller, D. V. (1986) Spontaneous aggregation as a mechanism for human monocyte purification. Cell. Immunol. 101, 312-319.
25. Bath, P. M. W., Booth, R. F. G., Hassal, D. G. (1989) Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J. Immunol. Methods 118, 59-65.
26. Kunsch, C., Medford, R. M. (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ. Res. 85, 753-766.
27. Kunt, T., Forst, T., Wilhelm, A., Tritschler, H., Pfuetzner, A., Harzer, O., Engelbach, M., Zschaebitz, A., Stoffi, E., Beyer, J. (1999) α-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced glycation end products. Clin. Sci. 96, 75-82.
28. Makita, Z., Vlassara, H., Cerami, A., Bucala, R. (1992) Immunochemical detection of advanced glycosylation end products in vivo. J. Biol. Chem. 267, 5133-5138.
29. Miyamoto, K., Hiroshiba, N., Tsujikawa, A., Ogura, Y. (1998) In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest. Ophthalmol. Vis. Sci. 39, 2190-2194.
30. Lu, M., Perez, V. L., Ma, N., Miyamoto, K., Peng, H. B., Liao, J. K., Adamis, A. P. (1999) VEGF increases retinal vascular ICAM-1 expression in vivo. Invest. Ophthalmol. Vis. Sci. 40, 1808-1812.
31. Kim, I., Moon, S. O., Kim, S. H., Kim, H. J., Koh, Y. S., Koh, G. Y. (2001) Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-κ B activation in endothelial cells. J. Biol. Chem. 276, 7614-7620.
32. Sone, H., Deo, B. K., Kumagai, A. K. (2000) Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest. Ophthalmol. Vis. Sci. 41, 1876-1884.
33. Marumo, T., Schini-Kerth, V. B., Busse, R. (1999) Vascular endothelial growth factor activates nuclear factor-κB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 48, 1131-1137.
34. Zhang, W. J., Frei, B. (2001) α-Lipoic acid inhibits TNF-α-induced NF-κB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J. 15, 2423-2432.
35. Lum, H., Roebuck, K. A. (2001) Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell Physiol. 280, C719-C741.
36. Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J. F., Michel, J. B. (2000) Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 20, 645-651.
37. Abiko, T., Abiko, A., Clermont, A. C., Shoelson, B., Horio, N., Takahashi, J., Adamis, A. P., King, G. L., Bursell, S. E. (2003) Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes 52, 829-837.
38. Joussen, A. M., Poulaki, V., Mitsiades, N., Kirchhof, B., Koizumi, K., Dohmen, S., Adamis, A. P. (2002) Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression. FASEB J. 16, 438-440.
39. Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C., Alexander, R. W. (2002) Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signalling and angiogenesis. Circ. Res. 91, 1160-1167.
40. Wang, Z., Castresana, M. R., Newman, W. H. (2001) Reactive oxygen and NF-κB in VEGF-induced migration of human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 285, 669-674.
41. Mamputu, J. C., Renier, G. (2004) Signalling pathways involved in retinal endothelial cell proliferation induced by advanced glycation end products. Inhibitory effect of gliclazide. Diabetes Obes. Metab. 6, 95-103.
42. Endo, M., Yanagisawa, K., Tsuchida, K., Okamoto, T., Matsushita, T., Higuchi, M., Matsuda, A., Takeuchi, M., Makita, Z., Koike, T. (2001) Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy. Horm. Metab. Res. 33, 317-322.
43. Stitt, A., Gardiner, T. A., Alderson, N. L., Canning, P., Frizzell, N., Duffy, N., Boyle, C., Januszewski, A. S., Chachich, M., Baynes, J. W., Thorpe, S. R., Anderson, N. L. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51, 2826-2832.